Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in IMNM — Immunome Inc.

CIK 861177 NEW YORK, NY

Position in IMNM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,997,194
-$92,734 QoQ
Shares Held
188,636
+0.9% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 200 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 43% Shared 0% None 57%

Common Shares in IMNM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. IMNM ranks #71 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMNM

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,997,194 188,636
2026-03-31 $4,089,928 187,011
2025-12-31 $2,658,127 123,749
2025-09-30 $1,315,009 112,298
2025-06-30 $1,736,291 186,698
2025-03-31 $527,254 78,344
2024-12-31 $618,009 58,193
2024-09-30 $641,306 43,865
2024-06-30 $629,852 52,054
2024-03-31 $288,756 11,700